NSE · Healthcare · Diagnostics & Research
EPS came in at 5.04 against a street estimate of 6.15 — a miss of 18.0%.
with an average price target of ₹841.00.
CONFIDENT Krsnaa reported 22% YoY revenue growth to INR 2,355M in Q1 FY'27. Rajasthan PPP project operationalized with 31 mother labs, 62 hub labs, and 1,228 collection centers live. Retail grew 64% YoY. EBITDA margins compressed to 25% from 27% due to upfront Rajasthan costs; management expects normalization and 10%+ margins by year-end. Q1 FY27 Rajasthan revenue expected to scale from INR 26Cr Q1 to INR 100–150Cr annualized (conservative guidance vs. earlier INR 200–250Cr target). New Himachal Pradesh 34-center CT project awarded; cash-paying, 10-year revenue visibility. Karnataka and HP receivables collections in process. Analysts pressed on margin drag (Rajasthan upfront manpower inflation), Rajasthan revenue ramp (cut from INR 200–250Cr to INR 100–150Cr), and retail customer acquisition without doctor commissions. Management defended compression as temporary infrastructure ramp, con…
Full summary in the app.
| Document | Date |
|---|---|
| Annual report FY2026 KRSNAA DIAGNOSTICS LIMITED – ANNUAL REPORT 2025-26 SUMMARY HEADLINE NUMBERS • Total Revenue from Operations: ₹7,727.74 million (FY2026) vs ₹7,171.60 | 2026-09-05 |
| Q1 FY27 earnings call KRSNAA DIAGNOSTICS LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Revenue from operations: INR 2,355 million (Q1 FY27) vs INR 1,930 million (Q1 FY26) | 2026-08-19 |
| Investor presentation · Q1 FY27 KRSNAA DIAGNOSTICS LIMITED - Q1 FY2026-27 SUMMARY HEADLINE NUMBERS • Revenue: ₹2,355 Mn (Q1 FY27) vs ₹1,930 Mn (Q1 FY26) = 22% YoY growth • EBITDA: | 2026-08-14 |
| Quarterly results · Q1 FY27 KRSNAA DIAGNOSTICS LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Q1 FY2026-27 Consolidated Revenue: INR 2,355.32 million (unaudited) • Q1 FY2026-27 | 2026-08-13 |
| Q4 FY26 earnings call KRSNAA DIAGNOSTICS LIMITED – Q4 FY'26 EARNINGS SUMMARY HEADLINE NUMBERS • Full Year FY'26 Revenue: INR 7,728 million (vs. INR 7,171 million in FY'25 | 2026-05-29 |
| Investor presentation · Q4 FY26 KRSNAA DIAGNOSTICS LIMITED – Q4 FY2025-26 SUMMARY HEADLINE NUMBERS • Q4 FY26 Revenue: ₹1,926 million vs ₹1,861 million Q4 FY25 (+4% YoY) • Full Year | 2026-05-25 |
| Quarterly results · Q4 FY26 KRSNAA DIAGNOSTICS LIMITED – FINANCIAL RESULTS SUMMARY Year Ended March 31, 2026 --- HEADLINE NUMBERS • Consolidated Revenue: ₹7,728 million for FY | 2026-05-25 |
| Q3 FY26 earnings call KRSNAA DIAGNOSTICS LIMITED – Q3 FY '26 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Q3 FY '26 Revenue: INR 1,812 million, representing 4% year-on | 2026-02-11 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹2.75 / share ex-date Sep 12, 2025 | 2025-09-12 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Krsnaa Diagnostics Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.